Marty Makary, the US Food and Drug Administration (FDA) Commissioner, is stepping down after just over a year in the role, as announced by President Donald Trump. Makary faced criticism for his stance against authorizing flavored vapes and tightening restrictions on abortion pills. Trump mentioned that Makary was experiencing difficulties and that a deputy would temporarily fill the position. Makary, a former surgeon at Johns Hopkins University, was known for advocating the Make America Healthy Again movement. His departure follows other high-profile exits under Health and Human Services Secretary Robert F. Kennedy Jr. Makary’s tenure included blocking FDA approval of certain vape flavors and approving a generic version of the abortion pill mifepristone, which drew criticism from health advocates and pharmaceutical companies. Trump praised Makary as a great doctor and friend, though it remains unclear if he resigned or was fired.
QUESTION: How might the frequent changes in leadership at health agencies impact public trust and policy continuity?
Marty Makary out as head of US Food and Drug Administration
